Clinical Trial Update: Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating organ preservation in rectal cancer using hypofractionated pelvic radiotherapy; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Snippet

Sponsor: Neil Kopek | Conditions: Colorectal Carcinoma | Phase 2 | Status: RECRUITING